CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Volume 16 Issue 2

The Great Why Questions About Dry Powder Inhalers  

The research pertains to the economic burden of asthma and chronic ob- structive pulmonary disease and the impact of poor inhalation techniques with commonly prescri...
Continue Reading →
Volume 16 Issue 2

Emerging Trends in Nasal Spray Development: Tools for Future Success 

A Brief History of Nasal Drug Delivery   Nasal drug delivery has significantly evolved since its inception several decades ago. Initially, it was primarily u...
Continue Reading →
Volume 16 Issue 2

Advances in Intranasal Vaccine Delivery: A Promising Non-Invasive Route of Immunisation  

Vaccination is an effective weapon for disease prevention and has been proven to significantly reduce the transmission of infections and the number of deaths worldwi...
Continue Reading →
Volume 16 Issue 2

Accelerating the Go-To-Market of Nasal Combination Products with Integrated Solutions   

Ear, Nose, Throat Market Trends Outlook  The overall Ear, Nose, and Throat (ENT) market was heavily impacted by Covid-19 pandemic due to masks-wearing, lockd...
Continue Reading →
Volume 16 Issue 1

Harnessing The Power of Solid Form and Particle Engineering to Overcome Solubility and Bioavailability Challenges

An Interview with Veranova’s Craig Grant Persistent challenges in poor solubility and low bioavailability have long impeded the pharmaceutical development pipelin...
Continue Reading →
Volume 16 Issue 1

Reaching the Marketplace

Understanding the Complexities of Paediatric Drug Development and Manufacturing Bringing a paediatric drug product to the marketplace can be very complex and also...
Continue Reading →
Volume 16 Issue 1

The Key to Formulation Development is in the Details

During the tablet manufacturing process, tooling and press manufacturers are often faced with ongoing challenges. As a tooling and press manufacturer, you should be ...
Continue Reading →
Volume 15 Issue 4

Ensuring a Robust Strategy to Navigate the Development of Challenging APIs

Small molecules as therapeutic agents have played a significant role in the improvement of human health and wellbeing since the discovery and commercialisation of mo...
Continue Reading →
Volume 15 Issue 4

Promising Platforms

How novel processing platforms incorporating new technologies can help to accelerate the development of cell and gene therapy processing, overcoming key industry cha...
Continue Reading →
Volume 15 Issue 4

Mastering the Immune Response: Immunogenicity Management in Biologics

The advent of therapeutic proteins and gene therapies has been a beacon of hope for treating complex diseases. Yet, these innovative treatments often face the signif...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026